original_dataset
stringclasses 7
values | instance_id
stringlengths 5
33
| phrase
stringlengths 1
166
| meddra_code
float64 10M
10.1M
⌀ | sct_id
float64 1.4M
571B
⌀ | umls_cui
stringlengths 8
8
⌀ | mapped_meddra_codes
stringlengths 8
62
| mapped_sct_ids
stringlengths 6
66
| single_mapped_meddra_codes
int64 10M
10.1M
| single_mapped_sct_ids
int64 450k
281,801B
|
|---|---|---|---|---|---|---|---|---|---|
TAC2017_ADR | DUREZOL.xml_AR25.N1 | increased lacrimation | 10,023,644 | null | null | 10023644 | 193982009 418035005 | 10,023,644 | 418,035,005 |
TAC2017_ADR | DUREZOL.xml_AR26.N1 | macular edema | 10,025,415 | null | null | 10025415 10058202 | 193387007 37231002 | 10,058,202 | 193,387,007 |
TAC2017_ADR | DUREZOL.xml_AR27.N1 | sclera hyperemia | 10,059,096 | null | null | 10059096 | 246980005 | 10,059,096 | 246,980,005 |
TAC2017_ADR | DUREZOL.xml_AR28.N1 | uveitis | 10,046,851 | null | null | 10046851 | 128473001 | 10,046,851 | 128,473,001 |
TAC2017_ADR | DUREZOL.xml_AR29.N1 | blurred vision | 10,047,513 | null | null | 10047513 | 111516008 246636008 | 10,047,513 | 246,636,008 |
TAC2017_ADR | DUREZOL.xml_AR31.N1 | headache | 10,019,211 | null | null | 10019211 | 25064002 | 10,019,211 | 25,064,002 |
TAC2017_ADR | DUREZOL.xml_AR32.N1 | increased iop | 10,022,806 | null | null | 10022806 | 112222000 | 10,022,806 | 112,222,000 |
TAC2017_ADR | DUREZOL.xml_AR34.N1 | dry eye | 10,013,774 | null | null | 10013774 | 162290004 | 10,013,774 | 162,290,004 |
TAC2017_ADR | DUREZOL.xml_AR35.N1 | iridocyclitis | 10,022,941 | null | null | 10022941 | 77971008 | 10,022,941 | 77,971,008 |
TAC2017_ADR | DUREZOL.xml_AR36.N1 | intraocular pressure increase | 10,022,806 | null | null | 10022806 | 112222000 | 10,022,806 | 112,222,000 |
TAC2017_ADR | DUREZOL.xml_AR37.N1 | iop increase | 10,022,806 | null | null | 10022806 | 112222000 | 10,022,806 | 112,222,000 |
TAC2017_ADR | ZYKADIA.xml_AR3.N1 | interstitial lung disease | 10,022,611 | null | null | 10022611 | 233703007 | 10,022,611 | 233,703,007 |
TAC2017_ADR | ZYKADIA.xml_AR4.N1 | pneumonitis | 10,035,742 | null | null | 10035742 | 205237003 | 10,035,742 | 205,237,003 |
TAC2017_ADR | ZYKADIA.xml_AR5.N1 | qt interval prolongation | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR6.N1 | hyperglycemia | 10,020,635 | null | null | 10020635 | 237598005 80394007 | 10,020,635 | 80,394,007 |
TAC2017_ADR | ZYKADIA.xml_AR7.N1 | bradycardia | 10,006,093 | null | null | 10019301 10006093 | 48867003 | 10,006,093 | 48,867,003 |
TAC2017_ADR | ZYKADIA.xml_AR8.N1 | pancreatitis | 10,033,645 | null | null | 10033645 | 75694006 | 10,033,645 | 75,694,006 |
TAC2017_ADR | ZYKADIA.xml_AR9.N1 | diarrhea | 10,012,735 | null | null | 10012735 | 267060006 62315008 | 10,012,735 | 62,315,008 |
TAC2017_ADR | ZYKADIA.xml_AR10.N1 | nausea | 10,028,813 | null | null | 10028813 | 422587007 | 10,028,813 | 422,587,007 |
TAC2017_ADR | ZYKADIA.xml_AR12.N1 | vomiting | 10,047,700 | null | null | 10047700 | 249497008 422400008 | 10,047,700 | 422,400,008 |
TAC2017_ADR | ZYKADIA.xml_AR13.N1 | abdominal pain | 10,000,081 | null | null | 10000081 10017999 | 21522001 | 10,000,081 | 21,522,001 |
TAC2017_ADR | ZYKADIA.xml_AR14.N1 | fatigue | 10,016,256 | null | null | 10016256 10003549 | 248274002 84229001 13791008 | 10,016,256 | 84,229,001 |
TAC2017_ADR | ZYKADIA.xml_AR15.N1 | decreased appetite | 10,061,428 | null | null | 10061428 | 64379006 | 10,061,428 | 64,379,006 |
TAC2017_ADR | ZYKADIA.xml_AR16.N1 | constipation | 10,010,774 | null | null | 10010774 | 14760008 | 10,010,774 | 14,760,008 |
TAC2017_ADR | ZYKADIA.xml_AR19.N1 | convulsion | 10,039,906 | null | null | 10039906 | 91175000 | 10,039,906 | 91,175,000 |
TAC2017_ADR | ZYKADIA.xml_AR20.N1 | pneumonia | 10,035,664 | null | null | 10035742 10035664 | 233604007 | 10,035,664 | 233,604,007 |
TAC2017_ADR | ZYKADIA.xml_AR21.N1 | ild | 10,022,611 | null | null | 10022611 | 233703007 | 10,022,611 | 233,703,007 |
TAC2017_ADR | ZYKADIA.xml_AR22.N1 | dyspnea | 10,013,968 | null | null | 10013968 | 230145002 267036007 | 10,013,968 | 267,036,007 |
TAC2017_ADR | ZYKADIA.xml_AR23.N1 | dehydration | 10,012,174 | null | null | 10012174 | 34095006 | 10,012,174 | 34,095,006 |
TAC2017_ADR | ZYKADIA.xml_AR24.N1 | fatal | 10,011,906 | null | null | 10011906 | 397709008 268923008 | 10,011,906 | 397,709,008 |
TAC2017_ADR | ZYKADIA.xml_AR25.N1 | respiratory failure | 10,038,695 | null | null | 10038695 | 409622000 | 10,038,695 | 409,622,000 |
TAC2017_ADR | ZYKADIA.xml_AR26.N1 | pneumothorax | 10,035,759 | null | null | 10035759 | 36118008 | 10,035,759 | 36,118,008 |
TAC2017_ADR | ZYKADIA.xml_AR27.N1 | gastric hemorrhage | 10,017,788 | null | null | 10017788 | 61401005 | 10,017,788 | 61,401,005 |
TAC2017_ADR | ZYKADIA.xml_AR29.N1 | pulmonary tuberculosis | 10,037,440 | null | null | 10037440 | 154283005 | 10,037,440 | 154,283,005 |
TAC2017_ADR | ZYKADIA.xml_AR30.N1 | cardiac tamponade | 10,007,610 | null | null | 10007610 | 35304003 | 10,007,610 | 35,304,003 |
TAC2017_ADR | ZYKADIA.xml_AR31.N1 | sepsis | 10,040,047 | null | null | 10040047 10077116 | 91302008 | 10,040,047 | 91,302,008 |
TAC2017_ADR | ZYKADIA.xml_AR32.N1 | upper abdominal pain | 10,000,087 | null | null | 10000087 | 83132003 | 10,000,087 | 83,132,003 |
TAC2017_ADR | ZYKADIA.xml_AR33.N1 | abdominal discomfort | 10,000,059 | null | null | 10000059 | 43364001 | 10,000,059 | 43,364,001 |
TAC2017_ADR | ZYKADIA.xml_AR34.N1 | epigastric discomfort | 10,053,155 | null | null | 10053155 | 119416008 | 10,053,155 | 119,416,008 |
TAC2017_ADR | ZYKADIA.xml_AR35.N1 | esophageal disorder | 10,061,318 | null | null | 10061318 | 37657006 | 10,061,318 | 37,657,006 |
TAC2017_ADR | ZYKADIA.xml_AR36.N1 | dyspepsia | 10,013,946 | null | null | 10013946 | 162031009 | 10,013,946 | 162,031,009 |
TAC2017_ADR | ZYKADIA.xml_AR37.N1 | gastroesophageal reflux disease | 10,017,885 | null | null | 10017885 | 235595009 698065002 | 10,017,885 | 235,595,009 |
TAC2017_ADR | ZYKADIA.xml_AR38.N1 | dysphagia | 10,013,950 | null | null | 10013950 | 40739000 288939007 | 10,013,950 | 40,739,000 |
TAC2017_ADR | ZYKADIA.xml_AR39.N1 | asthenia | 10,003,549 | null | null | 10003549 | 13791008 | 10,003,549 | 13,791,008 |
TAC2017_ADR | ZYKADIA.xml_AR40.N1 | rash | 10,037,844 | null | null | 10037844 | 271807003 | 10,037,844 | 271,807,003 |
TAC2017_ADR | ZYKADIA.xml_AR41.N1 | maculopapular rash | 10,037,868 | null | null | 10037868 | 247471006 | 10,037,868 | 247,471,006 |
TAC2017_ADR | ZYKADIA.xml_AR43.N1 | neuropathy | 10,029,331 | null | null | 10029331 | 386033004 302226006 | 10,029,331 | 302,226,006 |
TAC2017_ADR | ZYKADIA.xml_AR44.N1 | paresthesia | 10,033,775 | null | null | 10033775 | 91019004 | 10,033,775 | 91,019,004 |
TAC2017_ADR | ZYKADIA.xml_AR45.N1 | muscular weakness | 10,028,372 | null | null | 10028372 | 26544005 | 10,028,372 | 26,544,005 |
TAC2017_ADR | ZYKADIA.xml_AR46.N1 | gait disturbance | 10,017,577 | null | null | 10017577 | 22325002 | 10,017,577 | 22,325,002 |
TAC2017_ADR | ZYKADIA.xml_AR47.N1 | peripheral neuropathy | 10,029,331 | null | null | 10029331 | 302226006 | 10,029,331 | 302,226,006 |
TAC2017_ADR | ZYKADIA.xml_AR48.N1 | hypoesthesia | 10,020,937 | null | null | 10020937 | 59073000 | 10,020,937 | 59,073,000 |
TAC2017_ADR | ZYKADIA.xml_AR49.N1 | peripheral sensory neuropathy | 10,034,620 | null | null | 10034620 | 95662005 | 10,034,620 | 95,662,005 |
TAC2017_ADR | ZYKADIA.xml_AR50.N1 | dysesthesia | 10,013,886 | null | null | 10013886 | 279079003 | 10,013,886 | 279,079,003 |
TAC2017_ADR | ZYKADIA.xml_AR51.N1 | neuralgia | 10,029,223 | null | null | 10029223 | 16269008 | 10,029,223 | 16,269,008 |
TAC2017_ADR | ZYKADIA.xml_AR52.N1 | peripheral motor neuropathy | 10,034,580 | null | null | 10034580 10029331 | 95663000 128192007 | 10,034,580 | 95,663,000 |
TAC2017_ADR | ZYKADIA.xml_AR53.N1 | hypotonia | 10,021,118 | null | null | 10021118 10058909 | 398152000 398151007 | 10,021,118 | 398,152,000 |
TAC2017_ADR | ZYKADIA.xml_AR54.N1 | polyneuropathy | 10,036,105 | null | null | 10036105 | 42345000 | 10,036,105 | 42,345,000 |
TAC2017_ADR | ZYKADIA.xml_AR56.N1 | vision impairment | 10,047,571 | null | null | 10047571 | 397540003 7973008 | 10,047,571 | 397,540,003 |
TAC2017_ADR | ZYKADIA.xml_AR57.N1 | blurred vision | 10,047,513 | null | null | 10047513 | 111516008 246636008 | 10,047,513 | 246,636,008 |
TAC2017_ADR | ZYKADIA.xml_AR58.N1 | photopsia | 10,034,962 | null | null | 10034962 | 56170001 | 10,034,962 | 56,170,001 |
TAC2017_ADR | ZYKADIA.xml_AR59.N1 | accommodation disorder | 10,000,389 | null | null | 10000389 | 54552008 | 10,000,389 | 54,552,008 |
TAC2017_ADR | ZYKADIA.xml_AR60.N1 | presbyopia | 10,036,628 | null | null | 10036628 | 41256004 | 10,036,628 | 41,256,004 |
TAC2017_ADR | ZYKADIA.xml_AR61.N1 | reduced visual acuity | 10,047,531 | null | null | 10047531 | 13164000 | 10,047,531 | 13,164,000 |
TAC2017_ADR | ZYKADIA.xml_AR62.N1 | prolonged qt interval | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR63.N1 | hemoglobin decreased | 10,018,884 | null | null | 10018884 | 165397008 | 10,018,884 | 165,397,008 |
TAC2017_ADR | ZYKADIA.xml_AR72.N1 | bilirubin total increased | 10,005,364 | null | null | 10005364 | 26165005 176271000119108 | 10,005,364 | 26,165,005 |
TAC2017_ADR | ZYKADIA.xml_AR73.N1 | qtc interval prolongation | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR79.N1 | jaundice | 10,023,126 | null | null | 10023126 | 18165001 | 10,023,126 | 18,165,001 |
TAC2017_ADR | ZYKADIA.xml_AR81.N1 | total bilirubin 2 times the uln | 10,005,364 | null | null | 10005364 | 26165005 | 10,005,364 | 26,165,005 |
TAC2017_ADR | ZYKADIA.xml_AR82.N1 | ventricular tachyarrhythmias | 10,065,341 | null | null | 10065341 10047302 | 25569003 | 10,065,341 | 25,569,003 |
TAC2017_ADR | ZYKADIA.xml_AR83.N1 | torsade de pointes | 10,044,066 | null | null | 10044066 | 31722008 | 10,044,066 | 31,722,008 |
TAC2017_ADR | ZYKADIA.xml_AR85.N1 | qtc interval increase | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR86.N1 | qtc greater than 500 msec | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR87.N1 | increase from baseline qtc | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR88.N1 | increases in the qtc interval | 10,014,387 | null | null | 10014387 | 111975006 | 10,014,387 | 111,975,006 |
TAC2017_ADR | ZYKADIA.xml_AR89.N1 | sinus bradycardia | 10,040,741 | null | null | 10040741 | 49710005 | 10,040,741 | 49,710,005 |
TAC2017_ADR | ZYKADIA.xml_AR90.N1 | heart rate of less than 50 beats per minute | 10,019,301 | null | null | 10019301 10006093 | 48867003 | 10,019,301 | 48,867,003 |
TAC2017_ADR | ZYKADIA.xml_AR91.N1 | fatality | 10,011,906 | null | null | 10011906 | 397709008 268923008 | 10,011,906 | 397,709,008 |
TAC2017_ADR | CHOLINE.xml_AR1.N1 | injection site reaction | 10,022,095 | null | null | 10022095 | 95377006 | 10,022,095 | 95,377,006 |
TAC2017_ADR | CHOLINE.xml_AR2.N1 | allergic reactions | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | CHOLINE.xml_AR4.N1 | anaphylaxis | 10,002,198 | null | null | 10002198 10002199 | 39579001 | 10,002,198 | 39,579,001 |
TAC2017_ADR | CHOLINE.xml_AR5.N1 | cancer | 10,028,997 | null | null | 10028997 | 363346000 | 10,028,997 | 363,346,000 |
TAC2017_ADR | ERWINAZE.xml_AR1.N1 | hypersensitivity reactions | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | ERWINAZE.xml_AR2.N1 | pancreatitis | 10,033,645 | null | null | 10033645 | 75694006 | 10,033,645 | 75,694,006 |
TAC2017_ADR | ERWINAZE.xml_AR3.N1 | glucose intolerance | 10,018,429 | null | null | 10018429 | 267426009 9414007 | 10,018,429 | 9,414,007 |
TAC2017_ADR | ERWINAZE.xml_AR4.N1 | thrombosis | 10,043,607 | null | null | 10043607 | 439127006 | 10,043,607 | 439,127,006 |
TAC2017_ADR | ERWINAZE.xml_AR5.N1 | hemorrhage | 10,055,798 | null | null | 10015867 10055798 | 131148009 | 10,055,798 | 131,148,009 |
TAC2017_ADR | ERWINAZE.xml_AR6.N1 | systemic hypersensitivity | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | ERWINAZE.xml_AR7.N1 | hyperglycemia | 10,020,635 | null | null | 10020635 | 237598005 80394007 | 10,020,635 | 80,394,007 |
TAC2017_ADR | ERWINAZE.xml_AR9.N1 | fever | 10,037,660 | null | null | 10037660 10020843 10005911 | 386661006 | 10,037,660 | 386,661,006 |
TAC2017_ADR | ERWINAZE.xml_AR11.N1 | vomiting | 10,047,700 | null | null | 10047700 | 249497008 422400008 | 10,047,700 | 422,400,008 |
TAC2017_ADR | ERWINAZE.xml_AR12.N1 | nausea | 10,028,813 | null | null | 10028813 | 422587007 | 10,028,813 | 422,587,007 |
TAC2017_ADR | ERWINAZE.xml_AR13.N1 | hyperbilirubinemia | 10,020,578 | null | null | 10020578 | 14783006 166612004 | 10,020,578 | 14,783,006 |
TAC2017_ADR | ERWINAZE.xml_AR14.N1 | abdominal pain | 10,000,081 | null | null | 10000081 10017999 | 21522001 | 10,000,081 | 21,522,001 |
TAC2017_ADR | ERWINAZE.xml_AR15.N1 | abdominal discomfort | 10,000,059 | null | null | 10000059 | 43364001 | 10,000,059 | 43,364,001 |
TAC2017_ADR | ERWINAZE.xml_AR16.N1 | diarrhea | 10,012,735 | null | null | 10012735 | 267060006 62315008 | 10,012,735 | 62,315,008 |
TAC2017_ADR | ERWINAZE.xml_AR17.N1 | allergic reactions | 10,020,751 | null | null | 10020751 | 418634005 | 10,020,751 | 418,634,005 |
TAC2017_ADR | ERWINAZE.xml_AR18.N1 | allergy | 10,020,751 | null | null | 10013700 | 416098002 416093006 | 10,013,700 | 416,098,002 |
TAC2017_ADR | ERWINAZE.xml_AR19.N1 | coagulopathy | 10,009,802 | null | null | 10009802 10019009 | 64779008 | 10,009,802 | 64,779,008 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.